EMERGENCY MEDICAMENT DOSE CONTROL

Patent №

US 12,465,686

Granted

2025-11-11

Filed 2022

Owner

Beta Bionics, Inc.

Lab

AI components

0

Assignment

None on record

Dataset

AIPD

Application

17882469

Automated glucose level control system that provide therapy to a subject, such as glucose control, are disclosed. The system generates dose control signals using control algorithms configured to autonomously determine doses of insulin to be infused into a subject. When the system determines that an initial dose control signal does not indicate health-appropriate therapy, the system can modify a manual therapy instruction and transmit an emergency dose control signal to the medicament pump. Disclosed systems and devices can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject. The system can generate a backup therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.

A61M 5/14244A61M 5/1723G16H 20/17G16H 40/67G16H 15/00G16H 50/30G16H 50/20G16H 20/60+12 more

Ownership

Beta Bionics, Inc.

© 2026 NYSGPT2525 LLC